1 1

Prism Peptides

AOD 9604

AOD 9604

β‚±1,900.00 PHP
β‚±1,900.00 PHP
Sale Sold out
Set

πŸ”΄ IMPORTANT: Read Before Proceeding With Dosing

AOD-9604 (Anti-Obesity Drug 9604)

AOD-9604 is a modified fragment of human growth hormone (hGH) developed to support fat loss without the muscle-building effects, insulin changes, or side effects associated with full-length hGH.

Where GLP-1 agonists primarily suppress appetite and regulate insulin, AOD-9604 directly targets stored body fat:

  • Stimulates lipolysis (fat breakdown)

  • Inhibits lipogenesis (formation of new fat cells)

  • Blocks conversion of carbs into fat

  • Targets stubborn adipose reserves

This makes AOD-9604 an effective companion to GLP-1s for plateaus or for users who want fat-loss without appetite suppression.

βš™οΈ Mechanism of Action

AOD-9604 contains the TYR (Tyramine) portion of hGH responsible for fat-burning effects.
It activates lipid metabolism pathways without affecting insulin or growth pathways.

Function Effect Outcome
Lipolysis stimulation Breaks down stored fat Fat mobilization
Lipogenesis inhibition Blocks new fat cell formation Reduced fat accumulation
Joint & cartilage support Enhances repair Mobility & recovery
Collagen signaling Improves elasticity Skin tightening & firmness

✨ Additional Benefits

  • Increases metabolism & fat oxidation

  • Reduces formation of new fat cells

  • Improves collagen production

  • Supports cartilage & bone repair

  • Enhances joint mobility and flexibility

  • Anti-inflammatory benefits (arthritis support)

  • May prevent medication-related muscle loss

  • Does NOT affect blood sugar or insulin

⚠️ Possible Side Effects

Most users tolerate AOD-9604 well.
Reported effects may include:

  • Injection site irritation (redness, itching, swelling)

  • Headache or fatigue

  • Dizziness or cough

  • Chest tightness

  • Heart palpitations

  • Cold-like symptoms

Discontinue use if side effects escalate.

🚫 Contraindications

Do not use if:

  • Pregnant or breastfeeding

πŸ’§ Preparation

Vial Reconstitution
AOD-9604 β€” 5 mg Mix with 3 mL (300 units) β€” Acetic Acid ONLY

Use acetic acid, not bacteriostatic water, for proper solubility and stability.

πŸ’‰ Dosing & Administration

  • Subcutaneous injection

  • 5 days ON / 2 days OFF

  • Morning dosing for best results

  • Remain fasted β‰₯ 1 hour post-dose
    (3–4 hours ideal for fat-burning protocols)

Steady-state typically reached after ~3 weeks.
Fat-loss effects accelerate after this phase.

πŸ“† Cycle Duration Options

Cycle Duration Notes
Typical 8–12 weeks ON β†’ 8–12 weeks OFF Most common
Short 6–8 weeks Faster fat-loss push
Long Up to 6 months Maintenance style
Burst 20 days ON / 10 days OFF Popular micro-cycle

🎯 Dosing Protocols

🟒 Standard Protocol (General Body Recomp / Long Cycles)

18 units = 300 mcg, once daily

Timing Instructions
Morning Inject on empty stomach β†’ stay fasted β‰₯ 1 hr (3–4 hours optimal)

Steady, sustainable body-fat reduction & joint support

πŸ”₯ Weight Loss Protocol (Maximum Fat Loss / Short Cycles)

15 units = 250 mcg, twice daily

Timing Instructions
Morning Fasted dose
Evening β‰₯ 1 hour after dinner

Targets stubborn fat + plateaus
Often paired with GLP-1s or Tesamorelin for enhanced results

πŸ”— Stacking Suggestions

Goal Stack Why
Break plateaus GLP-1s (Semaglutide/Tirzepatide/Retatrutide) Appetite suppression + fat targeting
Joint & soft tissue repair BPC-157, TB-500 Regeneration + mobility
GH pathway support CJC-1295 (No DAC), Ipamorelin, Sermorelin Lean mass + recovery
Skin & elasticity GHK-Cu Collagen anchoring & tightness

Most popular pairing:
AOD-9604 + Tirzepatide or Retatrutide
β†’ Blocks stubborn fat while appetite is controlled.

🧠 Quick Reference

  • Morning β†’ fasted for best results

  • Expect visible changes after 3–6 weeks

  • Twice-daily dosing = fastest fat loss

  • Avoid carbohydrates immediately post-dose

  • Stack with GLP-1s to break plateaus

View full details